Well there is no enticement for retail buyers to push the price higher.
There ia enticement for instos to keep the price just below the CR - the lower the uptake, the more they can glean, and it is a certainty the retail component will be undersubscribed so no point debating that. And no enticement to push the price too far south by instos since they would both need fund the discount and buy their way out of it to make any gains from the CR.
As I see it, there has been bugger all retail participation in the stock in the last 6 months, so all up to instos to move the price. Sure some retail holders have bought on dips, but equally so, haven't seen a large exit whatsoever.
I have no idea where the other 99.9% of the stock I don't own is, but even with 1.6+b on issue, sod all is moving hands. About the only way instos will access more stock is to push the price up since the opposite sure has not worked.
I would not be surprised if a consolidation doesn't occur (and in the case of OBJ there would be little negative with that), so really in the instos interest to ensure they grab as much as possible before then while the price is in the sub 10c tick range.
More news would be welcome, moreso as a justification of fundamentals on the future. And increased revenue, but cannot see revenue decreasing. Main wild card is costs and given the dismal degree of news relating to internal plans including body guard and the use of CR funds, not surprised the retail sector is cagey - the board really should be more transparent, rather, issue info that promotes the company name even if the tech is a year coming. A strong brand name and market awareness even if the tech is not widely known cannot be underestimated! At least they could promote that - would rather it ve known that if the name OBJ used, people can say they knew of it and that it was responsible for tech a,b and c. Instead of people knowing tech a,b and c, and ehen asked about OBJ, responded, 'who?'...
Expand
(20min delay)